Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$246M |
| 2 |
ExxonMobil
XOM
|
+$96.1M |
| 3 |
Apple
AAPL
|
+$62M |
| 4 |
Verizon
VZ
|
+$58.6M |
| 5 |
Boeing
BA
|
+$52.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$174M |
| 2 |
SE
Spectra Energy Corp Wi
SE
|
+$85.4M |
| 3 |
STJ
St Jude Medical
STJ
|
+$69M |
| 4 |
Caterpillar
CAT
|
+$63.8M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.76% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 12.7% |
| 4 | Industrials | 11.05% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Avista
AVA
$3.24B
| $15.3M | 0.02% |
391,688
+31,473
| +9% | +$1.23M |
|
1002
CNX Resources
CNX
$5.2B
| $15.3M | 0.02% |
1,093,736
+140,722
| +15% | +$1.98M |
|
1003
Home BancShares
HOMB
$6.18B
| $15.3M | 0.02% |
564,662
+57,000
| +11% | +$1.57M |
|
1004
Workday
WDAY
$44.4B
| $15.3M | 0.02% |
183,437
+10,312
| +6% | +$856K |
|
|
B
1005
DELISTED
Barnes Group Inc.
B
| $15.3M | 0.02% |
297,561
+24,664
| +9% | +$1.21M |
|
|
RICE
1006
DELISTED
Rice Energy Inc.
RICE
| $15.3M | 0.02% |
643,889
+110,637
| +21% | +$2.3M |
|
|
UNIT
1007
Uniti Group
UNIT
$2.32B
| $15.3M | 0.02% |
589,958
+51,114
| +9% | +$1.36M |
|
|
TCF
1008
DELISTED
TCF Financial Corporation Common Stock
TCF
| $15.2M | 0.02% |
297,748
+33,004
| +12% | +$1.71M |
|
|
GHDX
1009
DELISTED
Genomic Health, Inc.
GHDX
| $15.2M | 0.02% |
482,675
+38,199
| +9% | +$1.13M |
|
1010
Generac Holdings
GNRC
$12.5B
| $15.2M | 0.02% |
407,647
+34,840
| +9% | +$1.38M |
|
1011
H.B. Fuller
FUL
$3.28B
| $15.2M | 0.02% |
294,159
+29,045
| +11% | +$1.45M |
|
|
AAT
1012
American Assets Trust
AAT
$1.4B
| $15.1M | 0.02% |
361,966
+194,231
| +116% | +$8.32M |
|
1013
UFP Industries
UFPI
$5.19B
| $15.1M | 0.02% |
461,058
+93,087
| +25% | +$3.11M |
|
1014
Bank of Hawaii
BOH
$3.13B
| $15.1M | 0.02% |
183,821
+30,832
| +20% | +$2.62M |
|
|
UNT
1015
DELISTED
UNIT Corporation
UNT
| $15.1M | 0.02% |
625,515
+85,829
| +16% | +$2.19M |
|
1016
Core Laboratories
CLB
$521M
| $15.1M | 0.02% |
130,775
+9,242
| +8% | +$1.07M |
|
1017
AMC Global Media
AMCX
$489M
| $15.1M | 0.02% |
257,067
-97,909
| -28% | -$5.62M |
|
|
MBFI
1018
DELISTED
MB Financial Corp
MBFI
| $15M | 0.02% |
351,308
+25,029
| +8% | +$1.12M |
|
1019
Neurocrine Biosciences
NBIX
$16.6B
| $15M | 0.02% |
346,906
+27,245
| +9% | +$1.17M |
|
|
RAD
1020
DELISTED
Rite Aid Corporation
RAD
| $15M | 0.02% |
176,502
+5,654
| +3% | +$681K |
|
|
COR
1021
DELISTED
Coresite Realty Corporation
COR
| $15M | 0.02% |
166,482
-13,431
| -7% | -$1.17M |
|
|
NSR
1022
DELISTED
Neustar Inc
NSR
| $15M | 0.02% |
452,246
+45,077
| +11% | +$1.5M |
|
1023
Group 1 Automotive
GPI
$3.18B
| $15M | 0.02% |
202,016
+23,738
| +13% | +$1.86M |
|
|
KITE
1024
DELISTED
Kite Pharma, Inc.
KITE
| $15M | 0.02% |
190,474
+17,132
| +10% | +$1.06M |
|
1025
Nektar Therapeutics
NKTR
$2.58B
| $14.9M | 0.01% |
42,240
+3,786
| +10% | +$851K |
|
Similar funds
Charles Schwab's Q1 2017 Portfolio in Review
As of Q1 2017, Charles Schwab held 3,112 positions worth $99.9B, up 9.4% from $91.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.38B of net new capital in Q1 2017, opening 37 new positions and adding to 2,360 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Chevron, an estimated $174M trimmed.
- Charles Schwab's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
- Charles Schwab added most to Home Depot in Q1 2017, an estimated $246M increase.
- Charles Schwab's biggest Q1 2017 reduction was Chevron, cutting an estimated $174M.
- Charles Schwab fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $85.4M.
- Charles Schwab's ten largest holdings make up 14% of its $99.9B portfolio in Q1 2017.
- Charles Schwab opened 37 new positions and closed 57 in Q1 2017.
- Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $99.9B.
Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.